The Cooper Companies, Inc.

(NASDAQ Global Select)
Back to all articles
Slightly Bullish +15

Cooper Companies Q3 2026 Earnings Preview β€” September 9, Street Expects $1.11 EPS - AlphaStreet

AI-generated analysis

πŸ“… Cooper Companies is scheduled to report Q3 fiscal 2026 earnings after market close on September 9th.

πŸ’° Analysts expect consensus EPS of $1.11 and revenue of $1.1 billion for the upcoming quarter.

πŸ“ˆ The expected EPS represents a modest 0.9% year-over-year increase from the prior period's $1.10 result.

πŸ“Š Revenue is projected to grow by 3.6% compared to the $1.07 billion reported in Q3 fiscal 2025.

πŸ›‘οΈ The company previously achieved a robust 64.7% gross margin and 16.4% operating margin in the prior quarter.

πŸ” Investors will watch for margin sustainability to gauge pricing power and manufacturing efficiency.

🌍 Segment-level performance and geographic mix, especially international markets, are critical drivers.

πŸš€ Management commentary on the product pipeline and regulatory approvals will frame future expectations.

πŸ’Ό The stock trades at $70.64 ahead of the earnings release to be tested against fundamental trajectory.

πŸ“‰ Recent execution shows a beat in the last quarter, though statistical significance for forecasting is limited.

Bullish Signals
  • Cooper Companies recently delivered a beat on consensus estimates in its last quarter, demonstrating consistent execution capabilities.
  • The company historically commands strong pricing power and manufacturing efficiency, evidenced by a 64.7% gross margin in the prior quarter.
Risk Factors
  • Analysts expect only minimal year-over-year earnings improvement of 0.9%, suggesting a measured bar for growth.
  • Revenue consensus sits slightly above the prior-year period, implying potential revenue softness or headwinds in core markets.
Full Analysis
The Cooper Companies, Inc. (NASDAQ: COO) is scheduled to report its third-quarter fiscal 2026 earnings results after the market close on September 9th. Wall Street analysts have set a consensus EPS estimate of $1.11 and revenue expectations at $1.1 billion. The anticipated earnings growth is modest, representing only a 0.9% increase over the year-ago result of $1.10 per share, while revenue is expected to rise by 3.6% compared to the prior period. Analysts are closely monitoring whether Cooper can maintain its historically strong profitability metrics, specifically the 64.7% gross margin and 16.4% operating margin recorded in the previous quarter. The company's recent track record of beating consensus estimates suggests consistent execution, but investors will scrutinize if this performance can be sustained amidst potential revenue headwinds or volume pressures. Key areas of focus for shareholders include segment-level performance across its diverse medical device categories and geographic mix, particularly how international markets compare to domestic operations. Management commentary regarding the product pipeline, regulatory approvals, and customer adoption trends will be critical in determining if the anticipated revenue softness is a temporary pause or signals a broader deceleration. The stock is currently trading at $70.64 as it approaches the earnings release, positioning investors to evaluate if actual results align with the modest growth expectations embedded in consensus estimates. The report will provide clarity on pricing discipline, operational efficiency, and future guidance for fiscal year 2026, which are essential for calibrating forward expectations regarding the company's core markets.